When AI designs a drug, who gets the credit?

Source: mitTechReview August 21, 2026 · 02:00
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…

The original article opens on the publisher's website.

More from General

View topic →